(2R,3S)-5-(2-(DIMETHYLAMINO)ETHYL)-2-(4-METHOXYPHENYL)-4-OXO-2,3,4,5-TETRAHYDRO-1,5-BENZOTHIAZEPIN-3-YL ACETATE
UNII H9R95ET7JS
Substance Identification & Data
This profile provides standardized clinical and technical data for (2r,3s)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl Acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H9R95ET7JS.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 111188-71-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H26N2O4S HSUGRBWQSSZJOP-NHCUHLMSSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2r,3s)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl Acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.